Financial Information for the Company and Its Subsidiaries (Tables)

9 Months Ended

Sep. 30, 2016

Condensed Financial Information of Parent Company Only Disclosure [Abstract]



Condensed Consolidating Balance Sheet - September 30, 2016 (In thousands)
	Parent Issuer		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Consolidating Adjustments			Total Consolidated
Assets
Current assets:
Cash and cash equivalents	$	3,858	$	7,287	$	94,913	$	—		$	106,058
Restricted cash and marketable securities	—		—		12,794		—			12,794
Accounts receivable, net	—		277,535		148,145		(785		)	424,895
Supplies inventory	—		—		22,505		—			22,505
Prepaid and other current assets	33,733		27,826		15,919		(13,024		)	64,454
Total current assets	37,591		312,648		294,276		(13,809		)	630,706
Property and equipment, net	11,740		36,855		178,618		—			227,213
Investments in and receivables from unconsolidated affiliates	5,282,324		1,754,313		—		(6,925,631		)	111,006
Goodwill	—		2,225,411		—		2,074,691			4,300,102
Intangible assets, net	12,967		1,664,170		1,790		—			1,678,927
Other assets	6,828		22,558		21,597		(1,998		)	48,985
Total assets	$	5,351,450	$	6,015,955	$	496,281	$	(4,866,747	)	$	6,996,939
Liabilities and Equity
Current liabilities:
Current portion of long-term debt	$	8,700	$	20	$	13,300	$	—		$	22,020
Accounts payable	1,751		1,877		27,252		(3,689		)	27,191
Accrued salaries and benefits	33,789		156,180		23,329		—			213,298
Accrued interest	18,565		—		12		—			18,577
Other accrued liabilities	12,563		43,242		55,940		(10,120		)	101,625
Total current liabilities	75,368		201,319		119,833		(13,809		)	382,711
Long-term debt	2,550,961		30		69,922		(29,018		)	2,591,895
Deferred income taxes	297,788		464,714		—		(1,998		)	760,504
Other long-term liabilities	7,613		98,324		23,960		—			129,897
Intercompany payable	—		1,228,157		—		(1,228,157		)	—
Noncontrolling interests – redeemable	—		—		60,908		116,969			177,877
Equity:
Total AmSurg Corp. equity	2,419,720		4,023,411		128,483		(4,151,894		)	2,419,720
Noncontrolling interests – non-redeemable	—		—		93,175		441,160			534,335
Total equity	2,419,720		4,023,411		221,658		(3,710,734		)	2,954,055
Total liabilities and equity	$	5,351,450	$	6,015,955	$	496,281	$	(4,866,747	)	$	6,996,939



Condensed Consolidating Balance Sheet - December 31, 2015 (In thousands)
	Parent Issuer		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Consolidating Adjustments			Total Consolidated
Assets
Current assets:
Cash and cash equivalents	$	20,437	$	27,507	$	58,716	$	—		$	106,660
Restricted cash and marketable securities	—		—		13,506		—			13,506
Accounts receivable, net	—		223,434		113,896		—			337,330
Supplies inventory	—		—		21,406		—			21,406
Prepaid and other current assets	28,739		39,046		16,062		(8,076		)	75,771
Total current assets	49,176		289,987		223,586		(8,076		)	554,673
Property and equipment, net	12,515		14,601		162,052		—			189,168
Investments in and receivables from unconsolidated affiliates	4,901,026		1,775,272		—		(6,507,128		)	169,170
Goodwill	—		1,956,741		—		2,013,469			3,970,210
Intangible assets, net	12,780		1,579,537		2,320		—			1,594,637
Other assets	4,653		1,717		17,078		(1,998		)	21,450
Total assets	$	4,980,150	$	5,617,855	$	405,036	$	(4,503,733	)	$	6,499,308
Liabilities and Equity
Current liabilities:
Current portion of long-term debt	$	8,700	$	—	$	11,677	$	—		$	20,377
Accounts payable	2,816		3,760		29,837		(3,852		)	32,561
Accrued salaries and benefits	31,510		158,705		12,322		—			202,537
Accrued interest	30,463		—		17		—			30,480
Other accrued liabilities	13,962		76,590		32,909		(4,224		)	119,237
Total current liabilities	87,451		239,055		86,762		(8,076		)	405,192
Long-term debt	2,326,103		—		55,249		(23,396		)	2,357,956
Deferred income taxes	268,573		432,923		—		(1,998		)	699,498
Other long-term liabilities	4,560		71,509		20,114		—			96,183
Intercompany payable	—		1,228,157		—		(1,228,157		)	—
Noncontrolling interests – redeemable	—		—		63,060		112,672			175,732
Equity:
Total AmSurg Corp. equity	2,293,463		3,646,211		132,267		(3,778,478		)	2,293,463
Noncontrolling interests – non-redeemable	—		—		47,584		423,700			471,284
Total equity	2,293,463		3,646,211		179,851		(3,354,778		)	2,764,747
Total liabilities and equity	$	4,980,150	$	5,617,855	$	405,036	$	(4,503,733	)	$	6,499,308

Condensed Consolidating Statement of Operations



Condensed Consolidating Statement of Operations - For the Three Months Ended September 30, 2016 (In thousands)
	Parent Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries		Consolidating Adjustments			Total Consolidated
Net revenue	$	8,671		$	471,190		$	358,955	$	(16,600	)	$	822,216
Operating expenses:
Salaries and benefits	20,106			333,420			108,659		(904		)	461,281
Supply cost	—			1,119			46,852		(19		)	47,952
Other operating expenses	6,367			48,186			76,052		(15,677		)	114,928
Transaction costs	8,036			8,870			—		—			16,906
Depreciation and amortization	1,134			22,444			8,007		—			31,585
Total operating expenses	35,643			414,039			239,570		(16,600		)	672,652
Net gain on disposals and deconsolidations	—			3,598			546		—			4,144
Equity in earnings of unconsolidated affiliates	79,314			67,427			—		(142,296		)	4,445
Operating income	52,342			128,176			119,931		(142,296		)	158,153
Interest expense (income), net	(6,948		)	39,069			794		—			32,915
Earnings before income taxes	59,290			89,107			119,137		(142,296		)	125,238
Income tax expense	19,336			9,802			520		—			29,658
Net earnings	39,954			79,305			118,617		(142,296		)	95,580
Less net earnings (loss) attributable to noncontrolling interests	—			(8		)	55,634		—			55,626
Net earnings attributable to AmSurg Corp. shareholders	39,954			79,313			62,983		(142,296		)	39,954
Preferred stock dividends	(2,264		)	—			—		—			(2,264		)
Net earnings attributable to AmSurg Corp. common shareholders	$	37,690		$	79,313		$	62,983	$	(142,296	)	$	37,690



Condensed Consolidating Statement of Operations - For the Nine Months Ended September 30, 2016 (In thousands)
	Parent Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries		Consolidating Adjustments			Total Consolidated
Net revenue	$	24,915		$	1,324,062		$	993,614	$	(37,198	)	$	2,305,393
Operating expenses:
Salaries and benefits	66,447			948,173			261,683		(1,172		)	1,275,131
Supply cost	—			3,271			141,399		(52		)	144,618
Other operating expenses	20,019			135,738			213,972		(35,974		)	333,755
Transaction costs	10,312			13,119			—		—			23,431
Depreciation and amortization	3,309			63,972			23,430		—			90,711
Total operating expenses	100,087			1,164,273			640,484		(37,198		)	1,867,646
Net gain on disposals and deconsolidations	—			6,455			284		—			6,739
Equity in earnings of unconsolidated affiliates	236,056			201,802			—		(419,483		)	18,375
Operating income	160,884			368,046			353,414		(419,483		)	462,861
Interest expense (income), net	(13,982		)	107,573			2,047		—			95,638
Earnings before income taxes	174,866			260,473			351,367		(419,483		)	367,223
Income tax expense	57,980			24,434			1,406		—			83,820
Net earnings	116,886			236,039			349,961		(419,483		)	283,403
Less net earnings (loss) attributable to noncontrolling interests	—			(15		)	166,532		—			166,517
Net earnings attributable to AmSurg Corp. shareholders	116,886			236,054			183,429		(419,483		)	116,886
Preferred stock dividends	(6,792		)	—			—		—			(6,792		)
Net earnings attributable to AmSurg Corp. common shareholders	$	110,094		$	236,054		$	183,429	$	(419,483	)	$	110,094



Condensed Consolidating Statement of Operations - For the Three Months Ended September 30, 2015 (In thousands)
	Parent Issuer			Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Consolidating Adjustments			Total Consolidated
Net revenue	$	5,975		$	339,484	$	314,382	$	(9,614	)	$	650,227
Operating expenses:
Salaries and benefits	17,642			231,769		78,249		(128		)	327,532
Supply cost	—			476		45,182		(20		)	45,638
Other operating expenses	7,054			34,742		66,522		(9,466		)	98,852
Transaction costs	270			1,837		—		—			2,107
Depreciation and amortization	1,017			14,906		8,183		—			24,106
Total operating expenses	25,983			283,730		198,136		(9,614		)	498,235
Net gain on disposals and deconsolidations	—			9,112		—		—			9,112
Equity in earnings of unconsolidated affiliates	96,232			64,423		—		(155,720		)	4,935
Operating income	76,224			129,289		116,246		(155,720		)	166,039
Interest expense, net	11,766			17,845		631		—			30,242
Earnings before income taxes	64,458			111,444		115,615		(155,720		)	135,797
Income tax expense	21,797			15,210		511		—			37,518
Net earnings	42,661			96,234		115,104		(155,720		)	98,279
Less net earnings attributable to noncontrolling interests	—			—		55,618		—			55,618
Net earnings attributable to AmSurg Corp. shareholders	42,661			96,234		59,486		(155,720		)	42,661
Preferred stock dividends	(2,264		)	—		—		—			(2,264		)
Net earnings attributable to AmSurg Corp. common shareholders	$	40,397		$	96,234	$	59,486	$	(155,720	)	$	40,397



Condensed Consolidating Statement of Operations - For the Nine Months Ended September 30, 2015 (In thousands)
	Parent Issuer			Guarantor Subsidiaries		Non-Guarantor Subsidiaries			Consolidating Adjustments			Total Consolidated
Net revenue	$	20,145		$	954,642	$	915,791		$	(27,956	)	$	1,862,622
Operating expenses:
Salaries and benefits	50,796			671,988		227,703			(380		)	950,107
Supply cost	—			1,361		132,705			(54		)	134,012
Other operating expenses	19,471			106,452		196,023			(27,522		)	294,424
Transaction costs	862			4,698		—			—			5,560
Depreciation and amortization	2,907			43,830		23,799			—			70,536
Total operating expenses	74,036			828,329		580,230			(27,956		)	1,454,639
Net gain (loss) on disposals and deconsolidations	—			5,889		(35		)	—			5,854
Equity in earnings of unconsolidated affiliates	233,362			183,519		—			(405,306		)	11,575
Operating income	179,471			315,721		335,526			(405,306		)	425,412
Interest expense, net	35,630			53,223		1,818			—			90,671
Earnings before income taxes	143,841			262,498		333,708			(405,306		)	334,741
Income tax expense	46,467			29,134		1,359			—			76,960
Net earnings	97,374			233,364		332,349			(405,306		)	257,781
Less net earnings attributable to noncontrolling interests	—			—		160,407			—			160,407
Net earnings attributable to AmSurg Corp. shareholders	97,374			233,364		171,942			(405,306		)	97,374
Preferred stock dividends	(6,792		)	—		—			—			(6,792		)
Net earnings attributable to AmSurg Corp. common shareholders	$	90,582		$	233,364	$	171,942		$	(405,306	)	$	90,582

Condensed Consolidating Statement of Cash Flows



Condensed Consolidating Statement of Cash Flows - For the Nine Months Ended September 30, 2016 (In thousands)
	Parent Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Consolidating Adjustments			Total Consolidated
Cash flows from operating activities:
Net cash flows provided by operating activities	$	79,353		$	226,593		$	389,490		$	(344,346	)	$	351,090
Cash flows from investing activities:
Acquisitions and related expenses	(296,689		)	(356,205		)	—			301,158			(351,736		)
Acquisition of property and equipment	(3,019		)	(35,450		)	(25,538		)	—			(64,007		)
Increase in cash due to consolidation of previously unconsolidated affiliates	—			—			31,412			—			31,412
Purchases of marketable securities	—			—			(498		)	—			(498		)
Maturities of marketable securities	—			—			2,987			—			2,987
Other, net	—			(2,217		)	(4,271		)	—			(6,488		)
Net cash flows provided by (used in) investing activities	(299,708		)	(393,872		)	4,092			301,158			(388,330		)
Cash flows from financing activities:
Proceeds from long-term borrowings	423,000			—			7,006			—			430,006
Repayment on long-term borrowings	(204,525		)	(14		)	(9,729		)	—			(214,268		)
Distributions to owners, including noncontrolling interests	—			(153,119		)	(363,302		)	344,346			(172,075		)
Capital contributions	—			296,689			—			(296,689		)	—
Changes in intercompany balances with affiliates, net	(5,621		)	—			5,621			—			—
Other, net	(9,078		)	3,503			3,019			(4,469		)	(7,025		)
Net cash flows provided by (used in) financing activities	203,776			147,059			(357,385		)	43,188			36,638
Net increase (decrease) in cash and cash equivalents	(16,579		)	(20,220		)	36,197			—			(602		)
Cash and cash equivalents, beginning of period	20,437			27,507			58,716			—			106,660
Cash and cash equivalents, end of period	$	3,858		$	7,287		$	94,913		$	—		$	106,058



Condensed Consolidating Statement of Cash Flows - For the Nine Months Ended September 30, 2015 (In thousands)
	Parent Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Consolidating Adjustments			Total Consolidated
Cash flows from operating activities:
Net cash flows provided by (used in) operating activities	$	(20,702	)	$	313,286		$	368,391		$	(233,773	)	$	427,202
Cash flows from investing activities:
Acquisitions and related expenses	(29,157		)	(236,107		)	—			31,774			(233,490		)
Acquisition of property and equipment	(5,659		)	(15,418		)	(25,929		)	—			(47,006		)
Purchases of marketable securities	—			—			(1,743		)	—			(1,743		)
Maturities of marketable securities	—			—			4,233			—			4,233
Other, net	—			(779		)	(3,195		)	—			(3,974		)
Net cash flows used in investing activities	(34,816		)	(252,304		)	(26,634		)	31,774			(281,980		)
Cash flows from financing activities:
Proceeds from long-term borrowings	—			—			10,197			—			10,197
Repayment on long-term borrowings	(6,525		)	—			(9,212		)	—			(15,737		)
Distributions to owners, including noncontrolling interests	—			(59,616		)	(332,301		)	233,773			(158,144		)
Capital contributions	—			29,157			—			(29,157		)	—
Changes in intercompany balances with affiliates, net	524			—			(524		)	—			—
Other, net	(4,102		)	2,653			1,871			(2,617		)	(2,195		)
Net cash flows used in financing activities	(10,103		)	(27,806		)	(329,969		)	201,999			(165,879		)
Net increase (decrease) in cash and cash equivalents	(65,621		)	33,176			11,788			—			(20,657		)
Cash and cash equivalents, beginning of period	134,351			23,471			50,257			—			208,079
Cash and cash equivalents, end of period	$	68,730		$	56,647		$	62,045		$	—		$	187,422